Omnicare Bolsters Case Against Ex-Merck VP, Investors Say
By Stephanie Russell-Kraft · March 26, 2015, 4:48 PM EDT
Shareholders accusing Merck & Co. Inc.'s former vice president of lying about the study results on Vioxx's heart attack link told a New Jersey federal court Wednesday that the U.S. Supreme...
To view the full article, register now.